Instil Bio (TIL) Assets (2020 - 2026)
Instil Bio (TIL) posted quarterly Assets of $200.4 million for Q1 2026, down 15.59% year-over-year from $237.4 million in Q1 2025, and down 1.52% quarter-over-quarter from $203.5 million in Q4 2025.
Instil Bio (TIL) Assets (2020 - 2026) Analysis & Trends
Instil Bio's Assets history runs 7 years deep, the most recent figure standing at $200.4 million for Q1 2026.
- In Q1 2026, Assets fell 15.59% year-over-year to $200.4 million; the TTM figure through Mar 2026 stood at $200.4 million (down 15.59% YoY), while the FY2025 annual figure was $203.5 million, down 22.78% from the prior year.
- Assets for Q1 2026 stood at $200.4 million, down from $203.5 million in the prior quarter.
- The five-year high for Assets was $568.5 million in Q2 2022, with the low at $200.4 million in Q1 2026.
- The 5-year median for Assets is $306.3 million (2024), against an average of $345.3 million.
- The sharpest annual moves came in 2022 and 2023: Assets decreased 15.48% in 2022, then slumped 36.13% in 2023.
- Instil Bio's Assets stood at $482.1 million in 2022, then tumbled by 32.46% to $325.6 million in 2023, then declined by 19.06% to $263.6 million in 2024, then dropped by 22.78% to $203.5 million in 2025, then declined by 1.52% to $200.4 million in 2026.
- Business Quant data shows TIL's Assets at $200.4 million in Q1 2026, $203.5 million in Q4 2025, and $211.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 5.56 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 2.10 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.82 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 25.60 Bn |
| 10 | Instil Bio | 50.29 Mn | 50.29 Mn | - | 197.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 197.71 Mn |
| Mar 31, 2026 | 200.43 Mn |
| Dec 31, 2025 | 203.52 Mn |
| Sep 30, 2025 | 211.77 Mn |
| Jun 30, 2025 | 230.99 Mn |
| Mar 31, 2025 | 237.45 Mn |
| Dec 31, 2024 | 263.57 Mn |
| Sep 30, 2024 | 272.56 Mn |
| Jun 30, 2024 | 294.32 Mn |
| Mar 31, 2024 | 306.30 Mn |
| Dec 31, 2023 | 325.63 Mn |
| Sep 30, 2023 | 340.27 Mn |
| Jun 30, 2023 | 408.31 Mn |
| Mar 31, 2023 | 427.17 Mn |
| Dec 31, 2022 | 482.13 Mn |
| Sep 30, 2022 | 532.74 Mn |
| Jun 30, 2022 | 568.54 Mn |
| Mar 31, 2022 | 564.94 Mn |
| Dec 31, 2021 | 609.98 Mn |
| Sep 30, 2021 | 647.40 Mn |